Healthy volunteers help compare two similar drugs in Early-Stage trial
NCT ID NCT02336347
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study enrolled 62 healthy adults to compare how two drugs, AVP-786 and AVP-923, are processed in the body. Participants received both drugs at different times to measure drug levels and safety. The goal was purely to gather information, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AVP-786 (deuterated dextromethorphan/quinidine) and AVP-923 (dextromethorphan/quinidine)
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Covance Dallas Clinical Research Unit
Dallas, Texas, 75247, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can eye movements reveal the Brain's visual priorities?
- A new eye on the brain: could this tracer unlock Addiction's secrets?
- First look: can a new drug candidate pass early safety tests in humans?
- A painless, contact-free vibration sensor may detect hidden heart and lung problems
- Can a Two-Pathway pill improve ED treatment? a new trial puts the combo to the test
- Could a common drug shield the brain from Alzheimer's?